Leading Element Driving Change in the Genome Sequencing Market in 2025: Rising Cancer Incidence Fuels Growth In The Genome Sequencing Market Driver

Which drivers are expected to have the greatest impact on the over the genome sequencing market's growth?
The surge in cancer instances is predicted to fuel the expansion of the genome sequencing market in the future. Cancer, a collection of diseases marked by unregulated growth and proliferation of abnormal cells, can be fatal if not managed. The rising incidence of cancer results from numerous variables, including an aging population, lifestyle habits, environmental hazards, and genetic susceptibility. Genome sequencing aids in pinpointing genetic aberrations and cancer predispositions, fostering early diagnosis and tailored treatment methods. It uncovers inherited susceptibility to cancer and aids in monitoring the evolution of cancerous cells. For example, the World Health Organization, a Swiss-based intergovernmental organization, projected in February 2024 that new cancer cases are set to surpass 35 million by 2050, equating to a 77% rise relative to 20 million cases in 2022. As such, the escalating prevalence of cancer is spurring the growth of the genome sequencing market.

Get Your Genome Sequencing Market Report Here:
https://www.thebusinessresearchcompany.com/report/genome-sequencing-global-market-report

What is the future CAGR of the genome sequencing market, and how will it impact industry expansion?
The market size of genome sequencing has experienced swift expansion lately. It is anticipated to escalate from $9.89 billion in 2024 to $11.78 billion in 2025, maintaining a CAGR of 19.1%. The surge observed in the historical phase emanates from factors such as escalated research funding, enhanced recognition of personalized medicine, a rise in genomic data, widening of clinical applications, and soaring demand for biomarker discovery.

The expansion of the genome sequencing market is anticipated in the upcoming years, with projections showing it reaching $23.63 billion in 2029, with a compound annual growth rate (CAGR) of 19.0%. This predicted growth in the forecast period can be linked to the advancement in genomic research, a surge in genetic disorders, escalating cancer rates, collaboration with other omics, and increased public understanding and acceptance. Forecast period trends incorporate the improvement in next-generation sequencing (NGS) technologies, harmonization with artificial intelligence (AI) and machine learning (ML), the proliferation of direct-to-consumer (DTC) genetic testing, the invention of portable sequencing machines, and the emergence of personalized medicine.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19484&type=smp

What are the most significant trends transforming the genome sequencing market today?
Key businesses within the genome sequencing industry are concentrating their efforts on creating innovative solutions, like Next-Generation Sequencing (NGS)-based assays, to improve the precision of genetic testing and facilitate personalized healthcare strategies. NGS-based assays are cutting-edge genomic techniques that enable speedy and high-throughput DNA or RNA sequencing for the analysis of genetic material. NGS permits simultaneous sequencing of millions of DNA or RNA fragments, swiftly producing significant amounts of data at reduced costs. For instance, in April 2023, Centogene N.V., a German firm specializing in rare disease genetic diagnostics, introduced CentoGenome, an amplified NGS-based assay. This service provides continuous diagnostic support throughout a patient's life with proactive diagnosis verification and categorization programs at no extra fees, ensuring constant patient care and exact disease control. CentoGenome, utilizing a PCR-free method, minimizes bias and amplifies the quality of sequencing, thereby improving coverage of challenging genomic regions and amplifying insights into coding, regulatory, and intronic regions. The platform includes an automated bioinformatics pipeline and expert medical analysis, tapping into CENTOGENE's significant bio-databank of data from approximately 700,000 patients across over 120 nations. This vast dataset enhances the identification of disease-triggering variants, including those connected to spinal muscular atrophy and Parkinson's disease.

Which key market segments comprise the genome sequencing market and drive its revenue growth?
The genome sequencingmarket covered in this report is segmented -

1) By Product: Consumables, Systems And Software, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction, Purification, Other Technologies
3) By Applications: Diagnostics, Drug Discovery, Precision Medicine, Environmental Genomics, Research, Other Applications
4) By End-User: Hospitals And Clinics, Biotechnology And Pharmaceutical Companies, Contract Research Organizations (CROs), Government, Research Centers, Academic And Government Institutes, Other End-Users

Subsegments:
1) By Consumables: Reagents And Kits, Sequencing Chips And Plates, Sample Preparation Products, Library Preparation Kits, DNA And RNA Extraction Kits
2) By Systems And Software: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Bioinformatics Software And Analysis Tools, Data Management And Storage Solutions, Laboratory Information Management Systems (LIMS)
3) By Services: Sequencing Services, Bioinformatics Analysis Services, Consultation And Support Services, Custom Genome Sequencing Solutions, Sample Collection And Preparation Services.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19484

What regions are at the forefront of genome sequencing market expansion?
North America was the largest region in the genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the genome sequencing market?
Major companies operating in the genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Eurofins Genomics, Agilent Technologies Inc., PerkinElmer, Illumina Inc., bioMérieux, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Group, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., LI-COR Inc., CENTOGENE N.V., Bioneer Corporation, Strand Life Sciences Pvt Ltd., Nebula Genomics

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19484&type=smp

What Is Covered In The Genome Sequencing Global Market Report?

•Market Size Forecast: Examine the genome sequencing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the genome sequencing market for a structured understanding.
•Key Players Overview: Analyze major players in the genome sequencing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the genome sequencing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the genome sequencing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the genome sequencing market.
•Industry Challenges: Identify potential risks and obstacles affecting the genome sequencing market.
•Competitive Landscape: Review strategic developments in the genome sequencing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.